Some weight management myths refuse to stay buried. You correct one in a consultation, and a fortnight later it’s back, carried in by a headline, a forum thread, or a well-meaning relative.
Three come up again and again: that BMI tells you everything, that nothing counts unless the scales move a long way, and that a weight management medicine does the work on its own. Current NICE guidance answers each of them clearly. This article is for pharmacists, nurse prescribers, and other practitioners who want a calm, accurate reply ready for the next time one of them rises again.
The short version
- BMI is a useful starting measure, but NICE asks you to interpret it with caution in some groups and to add waist-to-height ratio for many people.
- A modest weight loss can still improve health, and better eating has value even when the scales barely move.
- NICE says every weight management medicine should be used alongside a reduced-calorie diet and increased physical activity, with support for both.
- Correct the myth, not the person. Most people repeating one have simply heard it many times.
Why these myths keep rising
Weight management myths last because they’re simple, and the truth usually comes with a few conditions attached. “BMI over 30 means obesity” fits on a poster. “BMI is a practical measure, interpreted with caution in some groups and alongside waist-to-height ratio” does not.
They also spread faster than guidance updates. NICE published its combined guideline on overweight and obesity management (NG246) in January 2025, bringing together recommendations on assessment, diet and activity, behavioural support, and medicines. Plenty of what patients read online predates it.
There’s a human side as well. A myth often survives because it carries a judgement inside it, such as the idea that weight is purely about willpower. Our article on discussing weight without stigma covers the language that keeps those conversations respectful. Here, the focus is on the evidence itself.
Myth 1: “BMI tells you everything you need to know”
Body mass index (BMI) earns its place. It’s quick, it’s recorded widely, and NICE still uses it to classify overweight and obesity in adults. The trouble starts when it’s treated as the whole picture.
NICE’s recommendations on identifying and assessing overweight, obesity, and central adiposity set out several limits:
- Muscle mass. Interpret BMI with caution in adults with high muscle mass.
- Age. Interpret it with caution in people aged 65 and over, taking account of comorbidities and functional capacity.
- Ethnicity. People with a South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean background tend to have cardiometabolic risk at a lower BMI. NICE uses lower thresholds for these groups: overweight from 23 kg/m2 and obesity from 27.5 kg/m2.
Where waist-to-height ratio comes in
For people with a BMI under 35 kg/m2, NICE recommends measuring waist circumference so that waist-to-height ratio can be calculated. It classifies central adiposity as healthy at 0.4 to 0.49, increased at 0.5 to 0.59, and high at 0.6 or more. Those bands apply to both sexes and all ethnicities, including adults with high muscle mass.
In practice, a ratio under 0.5 simply means a waist measurement of less than half your height. That’s easy to explain and easy for a person to understand. It also picks up central fat, which is linked to type 2 diabetes, hypertension, and cardiovascular disease, in someone whose BMI looks unremarkable.
If you’ve seen the debate about newer measures such as the body roundness index, our piece asking whether BRI could replace BMI looks at that question. For day-to-day practice in the UK, the NICE measures are the ones to know well.
Myth 2: “If the scales haven’t moved much, it isn’t working”
This one is persistent because the number on the scales is the most visible result. It’s also the one most likely to make someone give up just as their health is starting to improve.
The NHS page on overweight and obesity in adults says that losing 5 to 10% of body weight can improve health. As an illustrative example, for someone weighing 110 kg that’s roughly 5.5 to 11 kg. That’s a long way from the dramatic weight-loss stories that circulate online, and it can still matter.
NICE goes further. It recommends encouraging people to improve their dietary intake even if this doesn’t result in weight loss, because there can be other benefits, such as an improved lipid profile and a reduced risk of type 2 diabetes and cardiovascular disease.
Changing what counts as progress
A conversation that measures success by weight alone leaves little room for anything else. Before you review progress, agree with the person which markers matter to them: blood pressure, a lipid result, waist measurement, energy levels, sleep, or simply managing the stairs without stopping.
NICE also warns against diagnostic overshadowing, which means attributing every symptom to a person’s weight. Keeping progress broader than the scales helps here too, because it keeps the whole person in view.
Myth 3: “The medicine does all the work”
Public interest in weight management medicines has grown quickly, and so has this myth. It usually appears as an expectation that once treatment starts, nothing else needs to change.
NICE is direct about it. In its section on medicines and surgery, it states that all medicines for weight management should be used alongside a reduced-calorie diet and increased physical activity. It also asks prescribers to discuss the potential impact on the person’s motivation, and to arrange information, support, and counselling on diet, physical activity, and behavioural strategies when medicines are prescribed.
The same section includes review points where treatment is reassessed if a set proportion of initial weight hasn’t been lost within a defined period. That only makes sense when the person understands from the start that the medicine is one part of a plan.
Setting expectations early
It’s easiest to bury this myth in the first consultation. Explain what the medicine is expected to do, what the person’s part in the plan looks like, and how progress will be reviewed. Our article on managing patient expectations during treatment covers that conversation in more depth.
The behavioural side is a skill in its own right, and it’s easy to underestimate. Our GLP-1 Agonists and Weight Management course teaches both the science behind the medicines and the coaching that helps people build and keep new habits.
Laying a myth to rest in practice
Knowing the evidence is half the job. The other half is delivering it in a way that doesn’t make anyone feel foolish for believing something they’ve heard many times.
- Ask first. Find out what the person has heard and where. “What have you read about this?” opens the door better than a correction.
- Acknowledge the logic. Most myths contain a grain of truth. BMI is useful, and medicines do have an effect.
- Give the current evidence plainly. One clear point from NICE or the NHS is more persuasive than a lecture.
- Make it personal. Link the evidence to the person’s own measurements, goals, or plan.
- Check understanding. Ask them to put the key point in their own words before they leave.
None of this needs a long consultation. It needs a practitioner who knows the evidence well enough to explain it simply.
Questions about weight management myths
Is it ever enough to use BMI on its own?
BMI remains NICE’s practical measure for classifying overweight and obesity in adults, so it’s rarely wrong to record it. The issue is relying on it alone. For many people, adding waist-to-height ratio and considering muscle mass, age, and ethnicity gives a far more accurate picture of risk.
Does waist-to-height ratio replace BMI?
No. NICE uses the two together. Waist-to-height ratio adds information about central adiposity, especially in people with a BMI under 35 kg/m2, while BMI still classifies overall weight category.
What if someone has improved their diet but their weight hasn’t changed?
Recognise the change. NICE recommends encouraging better dietary intake even without weight loss, because it can bring other health benefits. Review the markers you agreed together, rather than letting a static weight define the outcome.
How should I respond when a colleague repeats one of these myths?
The same way you’d respond to anyone else: with curiosity and the source. Sharing the relevant NICE recommendation is usually more effective than debating it, and it keeps the conversation professional.
Why do these myths spread so easily online?
Short, confident claims travel further than careful ones, and personal stories feel more convincing than guidance. Many posts also predate current recommendations, so the information was out of date before it was shared.
Will training on this change what I’m able to prescribe?
No. Training builds knowledge and confidence, but it doesn’t create prescribing rights or extend your scope of practice. Your professional regulator, your role, and your indemnity arrangements still define what you can do.
Keeping the myths buried
Myths will keep rising, because headlines and hearsay never stop. What changes the outcome is a practitioner who can answer them calmly, with the evidence to hand. If you’d like to build that confidence in weight management, contact MJ Clinical Training, email info@mjclinicaltraining.co.uk, or call 07769 003219, and tell us about your role and what you’d like to develop.


